Creotech Instruments (WAR:CRI) Other Current Liabilities: zł96.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:CRI Creotech Instruments SA WAR:CRI
72 GF Score
Price zł817.00
GF Value zł759.28
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Creotech Instruments Other Current Liabilities?

Creotech Instruments WAR:CRI -2.16% 72 Other Current Liabilities is zł96.1 Mil as of Mar. 2026. GuruFocus rates WAR:CRI with a GF Score™ of 72/100 and a GF Value™ of zł759.28 (Fairly Valued). The stock has 6 warning signs investors should review.

Creotech Instruments's other current liabilities for the quarter that ended in Mar. 2026 was zł96.1 Mil.

Creotech Instruments's quarterly other current liabilities increased from Sep. 2025 (zł24.0 Mil) to Dec. 2025 (zł88.0 Mil) and increased from Dec. 2025 (zł88.0 Mil) to Mar. 2026 (zł96.1 Mil).

Creotech Instruments's annual other current liabilities increased from Dec. 2023 (zł10.2 Mil) to Dec. 2024 (zł17.7 Mil) and increased from Dec. 2024 (zł17.7 Mil) to Dec. 2025 (zł88.0 Mil).

Creotech Instruments Other Current Liabilities Related Terms

Creotech Instruments Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Creotech Instruments's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creotech Instruments Other Current Liabilities Chart

Creotech Instruments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 2.40 6.66 10.20 17.67 88.02

Creotech Instruments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.06 32.79 24.05 88.02 96.13
WAR:CRI
72GF Score
Creotech Instruments SA WAR:CRI
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creotech Instruments Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of zł96.1 Mil mean?
Creotech Instruments (WAR:CRI) has a Other Current Liabilities of zł96.1 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Creotech Instruments.
Is Creotech Instruments' Other Current Liabilities too high?
Creotech Instruments' current Other Current Liabilities is zł96.1 Mil. Overall, Creotech Instruments has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' Other Current Liabilities compare to SPCX and GE?
Creotech Instruments' Other Current Liabilities of zł96.1 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for an Aerospace & Defense company?
A good Other Current Liabilities depends on the Aerospace & Defense industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Creotech Instruments. Creotech Instruments's current Other Current Liabilities is zł96.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Fairly Valued. The stock's GF Value™ is zł759.28, compared to a current price of zł817.00 — trading 7.6% above its estimated fair value. The current Other Current Liabilities is zł96.1 Mil. Creotech Instruments' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current Other Current Liabilities is zł96.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creotech Instruments (WAR:CRI) Overvalued in 2026?

Based on GuruFocus' analysis, Creotech Instruments stock appears to be overvalued. The current stock price of zł817.00 is trading 7.6% above its estimated GF Value™ of zł759.28. GuruFocus considers Creotech Instruments to be Fairly Valued.

Key valuation signals for WAR:CRI:

  • Other Current Liabilities: zł96.1 Mil
  • GF Value™: zł759.28 vs. price of zł817.00 (7.6% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creotech Instruments Business Description

Other Exchanges 5OB:Germany
Address Gen. L. Okulickiego 7/9, Piaseczno, POL, 05-500
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
72GF Score

Get the complete analysis for WAR:CRI

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł817.00
Price
zł759.28
GF Value